Oncology

Latest News

COVID-19 vaccine for patients with cancer. | Image Credit: Framestock - stock.adobe.com

COVID-19 Boosters Crucial for Patients With Cancer Despite Low Uptake

July 17th 2025

Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.

AJMC Q&A with Robert Kratzke | Background image credit: ipopba - stock.adobe.com

Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD

By Hayden E. Klein
Robert Kratzke, MD

July 15th 2025

The investigators found that patients with SCLC and cachexia were more likely to have problems with treatment. | Image credit: appledesign - stock.adobe.com

Cachexia Worsens Prognosis in Older Patients With Advanced SCLC

By Jared Kaltwasser

July 9th 2025

Insurance gaps | Image Credit: iQoncept-stock.adobe.com

Insurance Gaps Threaten Cancer Treatment Success

By Maggie L. Shaw

July 7th 2025

Analyzed by birth cohort, the authors found each successive birth cohort had a 7.7% decline in SCLC rates. | Image credit: shidlovski

Decline in SCLC Incidence Expected to Accelerate Through 2050

By Jared Kaltwasser

June 29th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

Continuing Medical Education

View All

July 21st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

July 21st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

October 8th 2014

Episode 11 - The Importance of Patient Education

October 8th 2014

Episode 10 - Comparative Effectiveness Research

October 8th 2014

Episode 9 - Analyzing Incentive Programs

October 8th 2014

Episode 8 - Immunotherapy and Pathways: Safety Considerations

October 8th 2014

Episode 7 - Inclusion of Generic Drugs in Pathways

October 8th 2014

Episode 6 - Measuring the Success of Clinical Pathways

October 8th 2014

Episode 5 - Utilization of Clinical Pathways in Oncology

October 8th 2014

Episode 4 - Potential Impact of Data Integration Projects

October 8th 2014

Episode 3 - Examining Data Integration Platforms

October 8th 2014

Episode 2 - Gaps in Data Exchange From a Payer Perspective

October 8th 2014

Episode 1 - Evidence-Based Decisions for Data Generation, Collection, and Analysis

October 8th 2014

Collaboration Will Help Match the Right Patient With the Right Trial

The collaboration between med fusion and GenomOncology promises improved outcomes in personalized cancer trials.

October 7th 2014

In The Literature: TNF-Î± Antagonists in RA Patients Reduces Cancer Risk

A Taiwan study found a significantly reduced risk of cancer among RA patients on biologics.

October 7th 2014

Cancer and Mental Health

Results of a large study performed across cancer centers in Germany, published online October 6, 2014 in the Journal of Clinical Oncology, show that 32% of people with cancer experienced some form of clinically relevant mental health challenge, such as anxiety, depressive and adjustment disorders.

October 6th 2014

Dr Peter B. Bach Outlines Framework for Tying Price of Cancer Drugs to Indication, Value

Mary K. Caffrey

Peter B. Bach, MD, MAPP, Memorial Sloan Kettering Cancer Center, writes in the Journal of the American Medical Association that cancer drugs could be charged different prices by indication, since the value for patients varies. His article appeared days before an appearance on 60 Minutes to discuss the high price of cancer drugs.

October 6th 2014

BMS to Collaborate with Novartis to Test Nivolumab in NSCLC

Combining nivolumab, an immuno-oncology molecule, with 1 of 3 targeted agents from Novartis is expected to improve patient response in NSCLC.

October 6th 2014

Study Identifies Lapses in Safe Chemotherapy Administration

Chemotherapy drugs, which could be poisons, can result in adverse health outcomes in healthcare workers who administer them to patients without adequate safety measures.

October 6th 2014

Vosaroxin Fails in Phase 3 AML Trials in the Elderly

Sunesis Pharmaceuticals announced the failure of a phase 3 study Monday morning. The company's experimental drug vosaroxin did not extend survival of elderly patients with advanced acute myeloid leukemia compared to a placebo.

October 5th 2014

Avoid Unnecessary Pap Tests: Study Concludes

A study published in the American Journal of Preventive Medicine found that lack of awareness resulted in women over 65 and those who had undergone hysterectomy routinely undergoing a Pap test.

October 5th 2014

ASCO Provides Input on CMMI's

ASCO has been working in parallel with various other institutions to generate a patient-centered oncology payment reform model.

October 5th 2014

In The Literature: NSAID/Statin Influence on PSA in High-Risk Prostate Cancer Patients

The study, published in Cancer Epidemiology, Biomarkers & Prevention, evaluated the influence of NSAIDs and statins on PSA levels in men with a high prostate cancer risk.

October 5th 2014

Ariad's Investigational NSCLC Drug: Breakthrough by FDA

The molecule is being evaluated in crizotinib-resistant ALK-positive NSCLC patients. The results from the phase 1/2 trial with AP26113 were presented at the 2014 European Cancer Congress.

October 4th 2014

JCO Study: MMA Did Not Influence Fee-For-Service Prescribing

The study by Kaiser Permanente found that prescription practices were not much influenced by the decrease in fee-for-service payments for outpatient chemotherapy, due the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.

October 4th 2014

Cigna Refers to NCCN Guidelines for Oncology Coverage Decisions

The Cigna-NCCN collaboration will benefit about 12.5 million members.

October 4th 2014

Merck's HPV Vaccine Effective Against 9 Subtypes

The study, conducted in Austria, evaluated the potency of the 9-valent vaccine in preventing the development of cervical precancer in women infected with HPV.

October 3rd 2014

Ambiguous Mammograms: An Emotional and Financial Burden

A study published in a supplement to the Journal of Women's Health looks to the widespread impact of newer screening technologies to improve outcomes.

October 3rd 2014

Value Discussion Reemerges at NICE: Roche's Gazyvaro Rejected

Following Kadcyla, NICE has now rejected another drug from Roche: Gazyvaro for CLL, citing ambiguities in the company's filing and the high cost.

October 3rd 2014

Literature: Germline BRCA Mutations Increase Susceptibility to Salivary Gland Cancer

The study, published online in JAMA Otolaryngology - Head & Neck Surgery, found a significant increase in the rate of head and neck cancers in individuals carrying a BRCA mutation.

October 2nd 2014

New Receptor Target for Glioblastoma Multiforme Holds Promise

A review published in Neuro-Oncology provides insight into some of the molecules being developed to target IL13RÎ±2 in brain tumors.

October 1st 2014

ASCO: Obesity a Risk Factor and Complication in Cancer

ASCO has called for raising awareness to control obesity, as it is not just a risk factor for developing diabetes but also for cancer.

...

151 152 153 154 155 156 157 158 159

...

186 >